Effects of acute liver injury on blood coagulation

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 4, 2003, Pages 754-759

  Kerr, R ^a   Newsome, P ^a   Germain, L ^a   Thomson, E ^a   Dawson, P ^a   Stirling, D ^a   Ludlam, C A ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Acute liver injury; Coagulation factors; Cytokines; Thrombin antithrombin

Indexed keywords

ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; BLOOD CLOTTING FACTOR; INTERLEUKIN 6; PARACETAMOL; PEPTIDE HYDROLASE; THROMBOPLASTIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOLOGICAL MODEL; BLOOD; BLOOD CLOTTING; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; MIDDLE AGED; PHYSIOLOGY;

ACETAMINOPHEN; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; HUMANS; INTERLEUKIN-6; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; MIDDLE AGED; MODELS, BIOLOGICAL; PEPTIDE HYDROLASES; THROMBOPLASTIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0142259266     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00194.x     Document Type: Article

References (30)

1. Pereira SP, Langley PG, Williams R. The management of abnormalities of hemostasis in acute liver failure. Semin Liver Dis 1996; 16: 403-14.
2. O'Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989; 97: 439-45.
3. von Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestim- mung des Fibrinogens. Acta Haematol 1957; 17: 237-46.
4. Dymock IW, Tucker JS, Woolf IL, Poller L, Thomson JM. Coagulation studies as a prognostic index in acute liver failure. Br J Haematol 1975; 29: 385-95.
5. Gazzard BG, Clark R, Borirakchanyavat V, Williams R. A controlled trial of heparin therapy in the coagulation defect of paracetamol- induced hepatic necrosis. Gut 1974; 15: 89-93.
6. Gazzard BG, Henderson JM, Williams R. Early changes in coagulation following a paracetamol overdose and a controlled trial of fresh frozen plasma therapy. Gut 1975; 16: 617-20.
7. Gazzard BG, Henderson JM, Williams R. The use of fresh frozen plasma or a concentrate of factor IX as replacement therapy before liver biopsy. Gut 1975; 16: 621-5.
8. Rake MO, Flute PT, Pannell G, Williams R. Intravascular coagulation in acute hepatic necrosis. Lancet 1970; i: 533-7.
9. Langley PG, Hughes RD, Williams R. Increased factor VIII complex in fulminant hepatic failure. Thromb Haemost 1985; 54: 693-6.
10. Stirling D, Hannant WA, Ludlam CA. Transcriptional activation of the factor VIII gene in liver cell lines by interleukin-6. Thromb Haemost 1998; 79: 74-8.
11. Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J Biol Chem 1999; 274: 19587-92.
12. Sarafanov AG, Ananyeva NM, Shima M, Saenko EL. Cell surface heparan sulfate proteoglycans participate in factor VIII catabolism mediated by low density lipoprotein receptor-related protein. J Biol Chem 2001; 276: 11970-9.
13. Ofosu FA, Liu L, Freedman J. Control mechanisms in thrombin generation. Semin Thromb Hemost 1996; 22: 303-8.
14. Monkovic DD, Tracy PB. Functional characterization of human plate-let-released factor V and its activation by factor Xa and thrombin. J Biol Chem 1990; 265: 17132-40.
15. Monkovic DD, Tracy PB. Activation of human factor V by factor Xa and thrombin. Biochemistry 1990; 29: 1118-28.
16. Osterud B, Rapaport SI. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 1977; 74: 5260-4.
17. Saliola M, Lorenzet R, Ferro D, Basili S, Caroselli C, Santo AD, Sallese M, Violi F. Enhanced expression of monocyte tissue factor in patients with liver cirrhosis. Gut 1998; 43: 428-32.
18. Neumann FJ, Ott I, Marx N, Luther T, Kenngott S, Gawaz M, Kotzsch M, Schomig A. Effect of human recombinant interleukin-6 and inter- leukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vase Biol 1997; 17: 3399-405.
19. Bevilacqua MP, Pober JS, Majeau GR, Fiers W, Cotran RS, Gimbrone MA Jr. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci USA 1986; 83: 4533-7.
20. Parry GC, Mackman N. Transcriptional regulation of tissue factor expression in human endothelial cells. Arterioscler Thromb Vase Biol 1995; 15: 612-21.
21. Simpson KJ. Cytokines, for better or worse? Eur J Gastroenterol Hepatol 1999; 11: 957-66.
22. Sekiyama KD, Yoshiba M, Thomson AW. Circulating proinflammatory cytokines (IL-1 beta, TNF-alpha, and IL-6) and IL-1 receptor antagonist (IL-IRa) in fulminant hepatic failure and acute hepatitis. Clin Exp Immunol 1994; 98: 71-7.
23. Blazka ME, Wilmer JL, Holladay SD, Wilson RE, Luster MI. Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol Appl Pharmacol 1995; 133: 43-52.
24. Duckert F. Behaviour of antithrombin 3 in liver disease. Scand J Gastroenterol Suppl 1973; 19: 109-12.
25. Langley PG, Forbes A, Hughes RD, Williams R. Thrombin-antithrom- bin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcome. Eur J Clin Invest 1990; 20: 627-31.
26. Ben Ari Z, Osman E, Hutton RA, Burroughs AK. Disseminated intravascular coagulation in liver cirrhosis: fact or fiction? Am J Gastroenterol 1999; 94: 2977-82.
27. Hutton RA, Laffan MA, Tuddenham EG. Normal Haemostasis. In: Postgraduate Haematology (Hoffbrand, AV, Lewis, SM, Tuddenham, EG, eds), 4th edn. Butterworth Heinemann 1999, 550-80.
28. Cardigan R, Sutherland J, Garwood M, Krailadsiri P, Seghatchian J, Beard M, Beckman N, Williamson LM. The effect of leucocyte depletion on the quality of fresh-frozen plasma. Br J Haematol 2001; 114: 233-40.
29. Chuansumrit A, Treepongkaruna S, Phuapradit P. Successful invasive procedures in children with liver failure using recombinant factor Vila. Haemophilia 2000; 6: 348.
30. Langley PG, Hughes RD, Forbes A, Keays R, Williams R. Controlled trial of antithrombin III supplementation in fulminant hepatic failure. J Hepatol 1993; 17: 326-31.